论文部分内容阅读
我国自70年代末开始进行现代生物技术的研究与开发,经过15年的发展,医药卫生、农林牧渔等领域特别是农作物育种和基因工程制药方面都已取得重要进展。在基因工程技术和细胞基因工程技术方面的研究水平与国外先进水平相比差距已不大,中下游技术有了很大的进展,中试基地建设为产业化打下基础,大中型制药企业已开始投入,产学研结合的模式已开始运作,生物技术药品开始产业化。据有关部门披露,目前α、γ干扰素、乙肝疫苗、促红细胞生长素、环孢菌素等已步入产业化阶段。上海、长春、沈阳、北京、成都等地的一批研究和生产生物技术产品的骨干企业迅速崛起,并在生物技术生产的厂房设计、工程实施、生产工艺、质量控制、经营管理等方面积累了经验。据统计,1995年全国生物技术产品的产值在5亿元以上,到本
China has been conducting research and development of modern biotechnology since the late 1970s. After 15 years of development, significant progress has been made in medical and health, agriculture, forestry, animal husbandry and fishery, especially in crop breeding and genetic engineering and pharmaceuticals. The gap between the level of research in genetic engineering technology and cell genetic engineering technology is not large compared with the advanced level in foreign countries. The technology in the middle and lower reaches has made great progress. The construction of pilot bases lays the foundation for industrialization, and large and medium-sized pharmaceutical companies have begun to Investment, the model of integration of production, education and research has begun to operate, and biotechnology medicines have begun to be industrialized. According to relevant departments, the current α, γ interferon, hepatitis B vaccine, erythropoietin, cyclosporine, etc. have entered the stage of industrialization. A group of key enterprises engaged in the research and production of biotechnology products in Shanghai, Changchun, Shenyang, Beijing, and Chengdu have rapidly emerged, and have accumulated experience in plant design, engineering implementation, production technology, quality control, and operation management of biotechnology production. experience. According to statistics, in 1995, the output value of national biotechnology products was over 500 million yuan.